Diagnostic News and Research

RSS

Neoprobe seeks FDA marketing approval of Lymphoseek for use in ILM oncology procedure

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced it has submitted a New Drug Application (NDA) for Lymphoseek to the U.S. Food and Drug Administration.

11 Aug 2011

China Medical receives SFDA approvals for TOP2A and prostate cancer FISH detection kits

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that it has received approvals for its prostate cancer FISH detection kit and Topoisomerase 2-alpha FISH detection kit from the State Food and Drug Administration of the People's Republic of China.

10 Aug 2011

TrovaGene regains ownership of worldwide rights to transrenal technology

TrovaGene, Inc., a developer of transrenal molecular diagnostics, confirmed today that it regained ownership of its worldwide rights and control over its patent estate for transrenal technology for non-invasive prenatal applications and cancer through the termination of a license agreement between TrovaGene and Sequenom, Inc.

10 Aug 2011

Improved patient selection and practice patterns may lower number of negative tests for CAD

Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.

10 Aug 2011

Nottingham researchers to develop new early warning system for Alzheimer's

Researchers at The University of Nottingham have been awarded £670,000 to develop a new early warning system for Alzheimer's disease.

9 Aug 2011

New Acromegaly clinical practice guidelines

Today the American Association of Clinical Endocrinologists (AACE) released updated Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly.

9 Aug 2011

GE Healthcare receives FDA clearance for Optima CT660 system

GE Healthcare today announced FDA clearance of Optima CT660 - a powerful and compact Computed Tomography (CT) system offering improvements from its predecessors in diagnostic capabilities at low dose levels, and designed for sustainability and ease-of-use.

9 Aug 2011

Debate on rationality of coronary angiography in low risk patients continues

A new study reveals that American hospitals vary widely in how they decide who's eligible for an invasive type of heart scan.

9 Aug 2011

Response Genetics second quarter total revenue increases 18.8% to $6.7 million

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated financial results and business progress for the second quarter ended June 30, 2011.

8 Aug 2011

Kaan Medikal to distribute Saladax's My5-FU diagnostic test in Turkey

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Kaan Medikal will serve as the exclusive distributor of Saladax's My5-FU diagnostic test throughout the Turkish market.

8 Aug 2011

FDA clears Toshiba's patient-friendly 3T MR system

In the 3T MR marketplace, patient compliance often impacts image quality and patient throughput. As the only 3T MR system designed to improve patient compliance and comfort while offering advanced radiology capabilities, Toshiba America Medical Systems, Inc.'s new Vantage TitanTM 3T open bore MR has received FDA clearance.

8 Aug 2011

NanoLogix BNP and BNF Quick Test kits detect, identify Group B Strep in four to six hours

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today that the American Journal of Perinatology has published a peer-reviewed paper from the University of Texas Health Science Center - Houston confirming NanoLogix BioNanoPore (BNP) and BioNanoFilter (BNF) Quick Test technology detect and identify Group B Strep in four to six hours.

8 Aug 2011

Leica Microsystems, CMED partner to co-develop and market automated FISH kits

China Medical Technologies, Inc. (CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, and Leica Biosystems, a division of Leica Microsystems, a world leader in microscopes and scientific instruments, today announced that they have established a sales, research and development collaboration to co-develop and market automated FISH kits to be used on the Leica BOND system.

8 Aug 2011

NHS doctors’ use of genetic tests leading to infringement of patent rights

NHS doctors are in trouble for over use of diagnostic genetic tests as these infringe upon patents. The British law now recognizes patents on the application of DNA discoveries. But doctors developing genetic tests in NHS hospitals tend to pay no heed to intellectual property.

8 Aug 2011

Merge Healthcare acquires Ophthalmic Imaging Systems

Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems, one of the country's top providers of digital imaging and informatics solutions for ophthalmology and other medical specialties, announced today the completion of Merge's acquisition of Ophthalmic Imaging Systems.

5 Aug 2011

Metallofullerene platform holds promise for treatment of brain tumors

A single compound with dual function - the ability to deliver a diagnostic and therapeutic agent - may one day be used to enhance the diagnosis, imaging and treatment of brain tumors, according to findings from Virginia Commonwealth University and Virginia Tech.

5 Aug 2011

Cancer Information Service celebrates helping one million Canadians

Fear, anxiety, helplessness, anger - these are some of the often overwhelming feelings that people can encounter when dealing with cancer. When faced with a cancer diagnosis, knowledge is power. The Canadian Cancer Society empowers Canadians with timely cancer information so that people can make informed decisions about their health.

5 Aug 2011

New polymer effectively captures nicotine molecules and analogues

Newly synthesized polymer, fitted with molecular pincers of carefully tailored structure, effectively captures nicotine molecules and its analogues.

5 Aug 2011

Akonni to develop closed amplicon RT-PCR microarray for virus detection in CSF

Akonni Biosystems, a molecular diagnostics company that develops novel nucleic acid extraction and microarray-based testing systems designed to rapidly and economically analyze biological samples, today announced receipt of a $300K grant from the National Institutes of Health.

5 Aug 2011

PCF funds 10 new Challenge Awards for prostate cancer research

The Prostate Cancer Foundation today announced that it has funded 10 new Challenge Awards for accelerating scientific discovery and new treatments for prostate cancer patients.

5 Aug 2011